Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease

Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed

Suzanne M. de la Monte, Jack R. Wands · Journal of Diabetes Science and Technology · 2008 · 1.1K citations · Full text

Medicine, Neurobiology, Neuroscience +17

Role of oxidative stress in Alzheimer's disease

Wenjuan Huang, Xia Zhang, Weiwei Chen · Biomedical Reports · 2016 · 1K citations · Full text

Life Sciences, Neurology, Neuroscience +17

Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology

Jane Kovalevich, Dianne Langford · Methods in molecular biology · 2013 · 999 citations

Life Sciences, Neurobiology, Neuroscience +8

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease

Shigeru Itagaki, P MCGEER, Haruhiko Akiyama et al. · Journal of Neuroimmunology · 1989 · 941 citations

Medicine, Neurobiology, Neuroscience +12

Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial

Juan P. Frías, Michael A. Nauck, Joanna Van et al. · The Lancet · 2018 · 799 citations

Medicine, Endocrinology, Pharmacology +17